ReShape Lifesciences (RSLS) entered into an exclusive agreement to import and distribute Motion Informatics' AI-powered neuromuscular rehabilitation devices in the US.
Haifa, Israel-based Motion Informatics' flagship product, the Stimel-03, has received clearance from the US Food and Drug Administration, ReShape Lifesciences said Wednesday in a statement.